Abstract
Background: Despite deprescribing initiatives to curb overutilization of proton pump inhibitors (PPIs), achieving meaningful reductions in PPI use is proving a challenge. Summary: An international group of primary care doctors and gastroenterologists examined the literature surrounding PPI use and use-reduction to clarify: (i) what constitutes rational PPI prescribing; (ii) when and in whom PPI use-reduction should be attempted; and (iii) what strategies to use when attempting PPI use-reduction. Key Messages: Before starting a PPI for reflux-like symptoms, patients should be educated on potential causes and alternative approaches including dietary and lifestyle modification, weight loss, and relaxation strategies. When commencing a PPI, patients should understand the reason for treatment, planned duration, and review date. PPI use at hospital discharge should not be continued without a recognized indication for long-term treatment. Long-term PPI therapy should be reviewed at least annually. PPI use-reduction should be based on the lack of a rational indication for long-term PPI use, not concern for PPI-associated adverse events. PPI use-reduction strategies involving switching to on-demand PPI or dose tapering, with rescue therapy for rebound symptoms, are more likely to succeed than abrupt cessation. © 2024 The Author(s). Published by S. Karger AG, Basel.
| Original language | English |
|---|---|
| Pages (from-to) | 211-220 |
| Number of pages | 10 |
| Journal | Dig. Dis. |
| Volume | 42 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 2024 |
Keywords
- Gastroesophageal reflux disease
- Oesophagus
- Proton pump inhibitors
- Gastroesophageal Reflux
- Humans
- Proton Pump Inhibitors
- nonsteroid antiinflammatory agent
- proton pump inhibitor
- anesthesia
- Barrett esophagus
- body weight loss
- duodenum ulcer
- dyspepsia
- esophagitis
- esophagus
- follow up
- gastroenterologist
- gastroesophageal reflux
- heartburn
- Helicobacter infection
- Helicobacter pylori
- human
- intensive care unit
- leisure
- lifestyle modification
- pharmacist
- polypharmacy
- prescription
- prevalence
- primary medical care
- randomized controlled trial (topic)
- Review
- risk factor
- treatment duration
- workshop
- Zollinger Ellison syndrome
- drug therapy
Fingerprint
Dive into the research topics of 'Proton Pump Inhibitors: Rational Use and Use-Reduction - The Windsor Workshop: Digestive Diseases'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver